NCT02381184View on ClinicalTrials.gov

Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

160

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

July 31, 2016

Conditions

Infertility

Interventions

DRUG

clomiphene citrate

receive100 mg of clomiphene citrate (Clomid®; Hoechst Marion Russel, Cairo, Egypt) daily starting on day 3 of spontaneous or progestin induced cycle for 10 days.

PROCEDURE

laparoscopic ovarian drilling (LOD)

Laparoscopy was performed under general anesthesia, using three-puncture technique

Trial Locations (1)

13518

Benha Faculty of Medicine, Banhā

All Listed Sponsors

lead

Benha University

OTHER

NCT02381184 - Extended Clomiphene Citrate Regimen in Women With Polycystic Ovary Syndrome | Biotech Hunter | Biotech Hunter